124 related articles for article (PubMed ID: 20218822)
1. The influence of other than prolactin hormones on bone mineral density in women with hyperprolactinaemia of various origins.
Bolanowski M; Zadrozna-Sliwka B; Jawiarczyk A; Syrycka J
Gynecol Endocrinol; 2010 Aug; 26(8):623-7. PubMed ID: 20218822
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density and bone turnover in hyperprolactinaemia of various origins.
Zadrozna-Sliwka B; Bolanowski M; Kałuzny M; Syrycka J
Endokrynol Pol; 2007; 58(2):116-22. PubMed ID: 17578827
[TBL] [Abstract][Full Text] [Related]
3. Sex steroids and bone turnover markers in men with symptomatic vertebral fractures.
Tuck SP; Scane AC; Fraser WD; Diver MJ; Eastell R; Francis RM
Bone; 2008 Dec; 43(6):999-1005. PubMed ID: 18817902
[TBL] [Abstract][Full Text] [Related]
4. Increase of bioavailable testosterone is associated with gain in bone mineral density after cure of primary hyperparathyroidism in postmenopausal women.
Almqvist EG; Becker C; Bondeson AG; Bondeson L; Svensson J
Clin Endocrinol (Oxf); 2006 Jan; 64(1):58-62. PubMed ID: 16402929
[TBL] [Abstract][Full Text] [Related]
5. The role of cyclase activating (CAP) and cyclase inhibiting (CIP) parathormone fractions in the assessment of bone metabolism disturbances in women with hyperprolactinemia of various origin.
Zadrozna-Sliwka B; Bolanowski M; Jawiarczyk A; Kaluzny M; Syrycka J
Neuro Endocrinol Lett; 2008 Feb; 29(1):178-84. PubMed ID: 18283239
[TBL] [Abstract][Full Text] [Related]
6. Lack of association of anabolic hormone status and muscle strength with regional and whole body bone mineral density in healthy men aged 60-79 years.
Taaffe DR; Cooper CS; Holloway L; Duret C; Marcus R
Aging (Milano); 1999 Feb; 11(1):4-11. PubMed ID: 10337436
[TBL] [Abstract][Full Text] [Related]
7. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study.
Yoshimura N; Kasamatsu T; Sakata K; Hashimoto T; Cooper C
J Bone Miner Metab; 2002; 20(5):303-10. PubMed ID: 12203037
[TBL] [Abstract][Full Text] [Related]
8. High bone turnover but normal bone mineral density in women suffering from schizophrenia.
Bergemann N; Parzer P; Mundt C; Auler B
Psychol Med; 2008 Aug; 38(8):1195-201. PubMed ID: 18366816
[TBL] [Abstract][Full Text] [Related]
9. IGF-I and testosterone levels as predictors of bone mineral density in healthy, community-dwelling men.
Rucker D; Ezzat S; Diamandi A; Khosravi J; Hanley DA
Clin Endocrinol (Oxf); 2004 Apr; 60(4):491-9. PubMed ID: 15049965
[TBL] [Abstract][Full Text] [Related]
10. [Decreased bone mineral density in pre-menopause women with prolactinoma].
Bussade I; Naliato EC; Mendonça LM; Violante AH; Farias ML
Arq Bras Endocrinol Metabol; 2007 Dec; 51(9):1522-7. PubMed ID: 18209896
[TBL] [Abstract][Full Text] [Related]
11. Hyperprolactinaemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma.
Sayki Arslan M; Sahin M; Topaloglu O; Tutal E; Karakose M; Gungunes A; Cakal E; Ozbek M; Delibasi T
Clin Endocrinol (Oxf); 2013 Dec; 79(6):882-6. PubMed ID: 23551036
[TBL] [Abstract][Full Text] [Related]
12. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study.
Greendale GA; Edelstein S; Barrett-Connor E
J Bone Miner Res; 1997 Nov; 12(11):1833-43. PubMed ID: 9383688
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and magnitude of osteopenia in patients with prolactinoma.
Kayath MJ; Lengyel AM; Vieira JG
Braz J Med Biol Res; 1993 Sep; 26(9):933-41. PubMed ID: 8298528
[TBL] [Abstract][Full Text] [Related]
14. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN.
Sowers MR; Finkelstein JS; Ettinger B; Bondarenko I; Neer RM; Cauley JA; Sherman S; Greendale GA;
Osteoporos Int; 2003 Jan; 14(1):44-52. PubMed ID: 12577184
[TBL] [Abstract][Full Text] [Related]
15. The role of serum PRL bioactivity evaluation in hyperprolactinaemic women with different menstrual disorders.
Kostrzak A; Warenik-Szymankiewicz A; Meczekalski B
Gynecol Endocrinol; 2009 Dec; 25(12):799-806. PubMed ID: 19905999
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of osteopenia in men with prolactinoma.
Naliato EC; Farias ML; Braucks GR; Costa FS; Zylberberg D; Violante AH
J Endocrinol Invest; 2005 Jan; 28(1):12-7. PubMed ID: 15816365
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density in patients with growth hormone deficiency: does a gender difference exist?
Hitz MF; Jensen JE; Eskildsen PC
Clin Endocrinol (Oxf); 2006 Dec; 65(6):783-91. PubMed ID: 17121531
[TBL] [Abstract][Full Text] [Related]
18. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
Wilhelm B; Kann PH
Med Klin (Munich); 2004 Oct; 99(10):569-77. PubMed ID: 15490072
[TBL] [Abstract][Full Text] [Related]
19. The risk of osteopenia in premenopausal women with various sellar tumors.
Zhao Y; Gan X; Luo P; He Q; Guo Q; Zhang L; Zhang X; Zhang X; Fei Z
Gynecol Endocrinol; 2012 Dec; 28(12):945-8. PubMed ID: 22553947
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men.
Johansson AG; Forslund A; Hambraeus L; Blum WF; Ljunghall S
J Bone Miner Res; 1994 Jun; 9(6):915-21. PubMed ID: 7521562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
